Download Unicorn Signals App

By EquityPandit

EquityPandit

EquityPandit
MARKETS

Paytm Shares Fall 8% as Exchanges Take on Big Block Deals

Shares of Paytm fell today on the buzz of big deals after rising for 4 consecutive sessions.

Shares of Paytm’s parent company, One 97 Communications fell more than 8% on February 10 following a block deal on exchanges, CNBC-TV18 reported.

About 2.1 crore Paytm shares, or a 3.4% stake, changed hands in the block trade. The buyer and seller could not be immediately identified.

Shares of the company fell 6.5% to Rs 666.4 at 9:50 am on the BSE.

Earlier this week, Paytm’s parent company reported its quarterly figures. Revenue in the December quarter jumped 41% to Rs 2,062 crore from a year earlier, while net loss narrowed to Rs 392 crore.

The digital payments and financial services company posted a loss of Rs 778 crore a year earlier, compared with Rs 572 crore in the September quarter.

Paytm founder and CEO Vijay Shekhar Sharma said in a letter to shareholders that the company achieved an operating profit in the third quarter, three quarters ahead of its guidance for the September quarter.

Goldman has said it expects profits to continue with solid growth in expenses, operating leverage and UPI reimbursement. At the same time, it raised its FY24 and FY25 adjusted EBITDA estimates by 30% and 14%, respectively, on the back of a significantly stronger third quarter.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.
MARKETS

Stocks Under F&O Ban: 

Ali Waghbakriwala

Under the futures and options (F&O) segment, no stocks were banned from trade on Friday, 25 April, by the National Stock Exchange (NSE). 

Derivative contracts of these stocks were banned as the open market interest for these securities has crossed 95% of the market-wide position limit (MWPL) set by the exchanges. The MWPL is the maximum number of contracts that can be opened at any particular time.

The ban will be lifted once the position falls below 80%. Traders will get penalised for buying or selling these securities. They will be available for trading in the cash market. 

The open interest for F&O contracts of RBL Bank declined below the 80% limit. Hence, it was removed from the list on Friday

The National Stock Exchange updates the list of securities on the F&O ban list daily. This list serves as a guide for traders and investors in the market. Traders who trade in indices do not encounter a situation of security ban.

Tired of missing hot stocks? Unicorn Signals provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!

MARKETS

Lupin Secures USFDA Approval for Tolvaptan Tablets; Shares Gain 

Ali Waghbakriwala

Shares of Lupin Ltd were trading in the green and 2% higher on Thursday, 24 April, after the company announced that USFDA (US Food and Drug Administration) had approved its Abbreviated New Drug Application (ANDA) for Tolvaptan tablets, which are intended to delay the deterioration of kidney function.

In an exchange filing, the company stated that it was the first to file for the product, providing it with 180 days of generic exclusivity. The medication is currently being produced at Lupin’s Nagpur facility and will be available shortly.

Tolvaptan delays the decline of kidney function in people suffering from rapidly progressive autosomal dominant polycystic kidney disease (ADPKD). According to Lupin’s exchange report, tablet sales in the United States will be over $1.47 billion by 2024.

“We are very pleased to have obtained approval for generic Tolvaptan from the USFDA. This marks a significant entry into the nephrology segment and demonstrates our commitment to addressing the unmet needs of patients globally,” said Lupin CEO Vinita Gupta.

Otsuka Pharmaceutical developed Tolvaptan tablets, a bioequivalent of Jynarque, to treat autosomal dominant polycystic kidney disease (ADPKD), a chronic condition with few therapies.

At 2:39 pm, the shares of Lupin Ltd were trading 0.69% higher at Rs 2,104 on NSE. 

Ask the analyst & get instant answer about Lupin Ltd.

Unlock profitable opportunities every day! Unicorn Signals provides actionable intraday trading signals for stocks and futures. Don’t miss out – download Unicorn Signals and start winning now!

MARKETS

Persistent Systems Shares Rally 4% on Strong Q4 Earnings 

Ali Waghbakriwala

Shares of Persistent Systems Ltd rallied 4% on 24 April after the company announced its quarterly earnings for the fourth quarter of the fiscal year 2025.

Persistent Systems reported a total net profit of Rs 395.76 crore for the period under review, reflecting a 25.5% year-on-year (YoY) rise over the net profit of Rs 315.32 crore achieved in Q4 FY24. In Q4 FY25, the company’s operating revenue rose by more than 25% year on year to Rs 3,242 crore.

For the fiscal year ending 31 March 2025, the IT company announced a final dividend of Rs 15 per equity share in addition to its Q4 results. According to an exchange filing, the record date for determining whether stockholders are eligible to receive the payout will be made public later. The dividend given this year now stands at Rs 35, which is noteworthy. According to the firm, it planned to commemorate its 35th anniversary.

Persistent CEO and Executive Director Sandeep Kalra said, “We are proud to have delivered our 20th sequential quarter of revenue growth, with an EBIT margin of 15.6%…Despite the uncertain macroeconomic environment, our consistent performance reflects the trust of our clients, enduring strength of our capabilities, and operational discipline.”

You Might Be Interested In

Sandeep added, “As we look ahead, we are optimistic about sustaining progress to reach $2 billion in annual revenue by FY27. Our strategic pivot to AI-led platform-driven services will drive this growth, fueled by continued rigor and innovation. We are well-positioned to continue delivering consistent and differentiated long-term value for all our stakeholders.”

For the fourth quarter of fiscal year 25, the firm reported a Total Contract Value (TCV) of $517.5 million and an Annual Contract Value (ACV) of $350.2 million.

Persistent Founder, Chairman and Managing Director Anand Deshpande said, “Persistent is leading the AI-led transformation, supported by early investments, strong execution, and a clear vision to embed AI across our clients’ digital journey. Celebrating 35 years since our foundation and 15 years of being publicly listed on the National Stock Exchange of India, our unwavering commitment to innovation and client success continues to set us apart as we drive the future of technology with purpose and precision.”

At 2:02 pm, the shares of Persistent Systems were trading 0.56% higher at Rs 5,192.50 on NSE.

Stay Ahead with Persistent Systems Ltd. Ask the Analyst.

Discover the next big investment! Unicorn Signals’ IPO screener helps you identify promising initial public offerings. Download Unicorn Signals and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!

MARKETS

Thyrocare Shares Skyrocket 18% on Stellar Q4 Earnings 

Ali Waghbakriwala

Shares of Thyrocare Technologies Ltd Skyrocketed 18% on Thursday, 24 April, after the company reported strong financial results for the January-March quarter (Q4FY25).

The company’s net profit for the quarter ending March 2025 climbed by 21.9% year on year (YoY) to Rs 21.7 crore from Rs 17.8 crore in the same period last year. Profit growth was driven mostly by improved operational performance and a consistent increase in the number of diagnostic tests performed.

The revenue for the quarter increased by 21.3% YoY, from Rs 154.3 crore in Q4FY24 to Rs 187.2 crore. EBITDA, or earnings before interest, taxes, depreciation, and amortisation, increased by 70.5% to Rs 57.8 crore.

As a result, the EBITDA margin jumped to 30.9% from 22% during the same time last year. This signifies enhanced operational efficiency and cost control.

The company’s board has recommended a final dividend of Rs 21 per equity share for FY25; shareholder approval is currently pending.

Thyrocare, headquartered in Navi Mumbai, operates a vast network of diagnostic and preventative healthcare laboratories throughout India. In recent quarters, the company has concentrated on increasing its test offerings and strengthening its digital presence, which has contributed to revenue growth driven by increased testing volumes.

At 12:24 pm, the shares of Thyrocare Tech were trading 13.44% higher at Rs 872.60 on NSE. 

Wondering About Thyrocare Technologies Ltd? The Analyst Has Answers.

The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!

MARKETS

Samhi Hotels Shares Soar 10% on Strategic Partnership with GIC 

Ali Waghbakriwala

Shares of Samhi Hotels Ltd soared 10% on 24 April after the company announced a strategic partnership with global institutional investor GIC. 

As part of the agreement, GIC would buy a 35% ownership in Samhi’s subsidiaries, which include the upscale hotels Hyatt Regency in Pune, Courtyard & Fairfield by Marriott in Bengaluru ORR, and the recently acquired Trinity Hotel in Bengaluru Whitefield.  

The aforementioned transaction, with an enterprise value of Rs 2,200 crore, would require an investment of around Rs 752 crore, from which Rs 603 crore of the amount would be used to pay off Samhi’s debt and cover transaction expenses. The remaining funds will be used to partially fund capital expenditures for the dual-branded Westin or Tribute Portfolio Bengaluru Whitefield hotel over the next two years.

You Might Be Interested In

Following the transaction, the company intends to reduce its debt by approximately Rs 580 crore. Samhi estimated that this would raise the company’s net profit by 15%-20%.  Furthermore, its net debt-to-EBITDA ratio is forecast to reduce from 4.9x to 3.5x following the deal and subsequently to 3x during the following year.

The company, in its regulatory filing, added, “The transaction follows our stated strategy of capital recycling and will lead to significant reduction in debt and partnership with a global investor of GIC’s stature for funding further growth.”

The company added that the debt reduction and partial finance of new projects will significantly increase its future cashflows.

At 11:42 am, the shares of Samhi Hotels were trading 9.22% higher at Rs 190 on NSE. 

Curious About Samhi Hotels Ltd? Ask the Analyst.

Feeling overwhelmed by the markets? Let Unicorn Signals be your guide. Our user-friendly app simplifies complex data and provides actionable trading signals. Download the app today and trade with confidence!

@2025 - www.equitypandit.com. All Right Reserved.
Latest
IPO
Weekly
Outlook

Stock
Market
Prediction